Literature DB >> 8086193

Hepatitis C virus: historical perspective and current concepts.

R H Purcell1.   

Abstract

Over the past 30 years, hepatitis C has emerged from shadowy enigma to important public health problem. The existence of the etiological agent of this disease was first appreciated two decades ago but significant progress in its understanding had to await its molecular characterization within the past 5 years. The virus is a member of the family Flaviviridae and is the cause of approximately 20% of clinical viral hepatitis in the United States. While the control of the transmission of hepatitis C virus in blood and blood products has been nothing less than spectacular, the control of community-acquired hepatitis C will be a major challenge to the scientific and medical communities.

Entities:  

Mesh:

Year:  1994        PMID: 8086193     DOI: 10.1111/j.1574-6976.1994.tb00087.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  8 in total

1.  Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.

Authors:  R Zhang; J Durkin; W T Windsor; C McNemar; L Ramanathan; H V Le
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 3.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

4.  Comparative features of hepatitis C virus infection in humans and chimpanzees.

Authors:  C M Walker
Journal:  Springer Semin Immunopathol       Date:  1997

5.  A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.

Authors:  Bambang S Adiwijaya; Eva Herrmann; Brian Hare; Tara Kieffer; Chao Lin; Ann D Kwong; Varun Garg; John C R Randle; Christoph Sarrazin; Stefan Zeuzem; Paul R Caron
Journal:  PLoS Comput Biol       Date:  2010-04-15       Impact factor: 4.475

6.  Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses.

Authors:  G Filocamo; L Pacini; C Nardi; L Bartholomew; M Scaturro; P Delmastro; A Tramontano; R De Francesco; G Migliaccio
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  In vitro phenotypic characterization of hepatitis C virus NS3 protease variants observed in clinical studies of telaprevir.

Authors:  Min Jiang; Nagraj Mani; Chao Lin; Andrzej Ardzinski; Michelle Nelson; Dugan Reagan; Doug Bartels; Yi Zhou; Olivier Nicolas; B Govinda Rao; Ute Müh; Brian Hanzelka; Ann Tigges; Rene Rijnbrand; Tara L Kieffer
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

8.  Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.

Authors:  Gururaj Kalkeri; Chao Lin; Jenna Gopilan; Kevin Sloan; Rene Rijnbrand; Ann D Kwong
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.